GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (BOM:532872) » Definitions » Degree of Operating Leverage

Sun Pharma Advanced Research Co (BOM:532872) Degree of Operating Leverage : 2.67 (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co Degree of Operating Leverage?

Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. Sun Pharma Advanced Research Co's Degree of Operating Leverage for the quarter that ended in Mar. 2025 was 2.67. The higher Degree of Operating Leverage, the higher operating risk the company will take.

The industry rank for Sun Pharma Advanced Research Co's Degree of Operating Leverage or its related term are showing as below:

BOM:532872's Degree of Operating Leverage is ranked worse than
71.53% of 952 companies
in the Drug Manufacturers industry
Industry Median: 0.62 vs BOM:532872: 2.67

Sun Pharma Advanced Research Co Degree of Operating Leverage Historical Data

The historical data trend for Sun Pharma Advanced Research Co's Degree of Operating Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co Degree of Operating Leverage Chart

Sun Pharma Advanced Research Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Degree of Operating Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.24 -0.77 0.18 -1.16 2.67

Sun Pharma Advanced Research Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Degree of Operating Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.16 -0.96 -0.85 -0.13 2.67

Competitive Comparison of Sun Pharma Advanced Research Co's Degree of Operating Leverage

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharma Advanced Research Co's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharma Advanced Research Co's Degree of Operating Leverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharma Advanced Research Co's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where Sun Pharma Advanced Research Co's Degree of Operating Leverage falls into.


;
;

Sun Pharma Advanced Research Co Degree of Operating Leverage Calculation

Sun Pharma Advanced Research Co's Degree of Operating Leverage for the quarter that ended in Mar. 2025 is calculated as:

Degree of Operating Leverage=% Change in EBIT**/% Change in Revenue
=( -3337.4 (Mar. 2025) / -3851.4 (Mar. 2024) - 1 )/( 717.7 (Mar. 2025) / 755.5 (Mar. 2024) - 1 )
=-0.1335/-0.05
=2.67***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Sun Pharma Advanced Research Co  (BOM:532872) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.


Sun Pharma Advanced Research Co Degree of Operating Leverage Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharma Advanced Research Co Business Description

Traded in Other Exchanges
Address
Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines